FilingReader Intelligence

CSPC Innovation's asset acquisition plan terminated

May 12, 2025 at 07:13 AM UTC•By FilingReader AI

CSPC Innovation Pharmaceutical (SZSE:300765) announced that the Shenzhen Stock Exchange (SZSE) has terminated its review of the company's application to issue shares to purchase assets and raise supporting funds. The decision was made following CSPC Innovation's application to withdraw the relevant documents.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Announcement on Receipt of the Shenzhen Stock Exchange's "Decision on Terminating the Review of the Application for Issuance of Shares by CSPC Pharmaceutical Innovations Co., Ltd. to Purchase Assets and Raise Matching Funds"May 5, 2025 at 11:42 PM UTC

Supplementary Source Documents

Announcement on the completion of the implementation of the controlling shareholder's plan to increase the company's sharesMay 8, 2025 at 11:32 AM UTC

CSPC Innovation Pharmaceutical

SZSE:300765•Shenzhen Stock Exchange

RSS feed for CSPC Innovation Pharmaceutical

News Alerts

Get instant email alerts when CSPC Innovation Pharmaceutical publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →